Overview
HNRNPA1-related adult-onset distal myopathy is a rare inherited muscle disease caused by changes (mutations) in the HNRNPA1 gene. This gene provides instructions for making a protein involved in processing RNA, which is a key step in how your body uses genetic information to build proteins. When this gene is not working properly, it leads to progressive weakness in the muscles farthest from the center of the body, particularly the hands and feet. This condition is sometimes also referred to as inclusion body myopathy associated with HNRNPA1 mutations or multisystem proteinopathy. Symptoms typically begin in adulthood and tend to worsen slowly over time. People often first notice difficulty with tasks that require fine hand movements or weakness in the lower legs and feet, which can cause tripping or foot drop. Some individuals may also develop features that overlap with other conditions such as Paget disease of bone or, in rare cases, frontotemporal dementia, because the HNRNPA1 protein is involved in a broader group of diseases called multisystem proteinopathies. There is currently no cure for this condition. Treatment focuses on managing symptoms and maintaining function for as long as possible. This may include physical therapy, occupational therapy, assistive devices like braces or splints, and regular monitoring by a team of specialists. Research is ongoing to better understand the disease and develop targeted therapies.
Key symptoms:
Weakness in the hands and fingersWeakness in the feet and lower legsFoot drop (difficulty lifting the front of the foot)Difficulty with fine motor tasks like buttoning clothesMuscle wasting in the hands and lower legsTripping or stumbling when walkingProgressive difficulty walkingMuscle twitching or crampingBone pain or fractures (if Paget disease of bone develops)Fatigue during physical activitiesGradual loss of grip strength
Clinical phenotype terms (16)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for HNRNPA1-related adult-onset distal myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for HNRNPA1-related adult-onset distal myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for HNRNPA1-related adult-onset distal myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to HNRNPA1-related adult-onset distal myopathy.
Community
No community posts yet. Be the first to share your experience with HNRNPA1-related adult-onset distal myopathy.
Start the conversation →Latest news about HNRNPA1-related adult-onset distal myopathy
No recent news articles for HNRNPA1-related adult-onset distal myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How quickly is this disease likely to progress in my case?,Should I be screened for Paget disease of bone or other features of multisystem proteinopathy?,What types of physical therapy or exercises are best for maintaining my muscle strength?,Should my family members be tested for the HNRNPA1 gene mutation?,Are there any clinical trials or research studies I could participate in?,How often should I have follow-up appointments and what tests should be done regularly?,What assistive devices or home modifications might help me stay independent longer?
Common questions about HNRNPA1-related adult-onset distal myopathy
What is HNRNPA1-related adult-onset distal myopathy?
HNRNPA1-related adult-onset distal myopathy is a rare inherited muscle disease caused by changes (mutations) in the HNRNPA1 gene. This gene provides instructions for making a protein involved in processing RNA, which is a key step in how your body uses genetic information to build proteins. When this gene is not working properly, it leads to progressive weakness in the muscles farthest from the center of the body, particularly the hands and feet. This condition is sometimes also referred to as inclusion body myopathy associated with HNRNPA1 mutations or multisystem proteinopathy. Symptoms typ
How is HNRNPA1-related adult-onset distal myopathy inherited?
HNRNPA1-related adult-onset distal myopathy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does HNRNPA1-related adult-onset distal myopathy typically begin?
Typical onset of HNRNPA1-related adult-onset distal myopathy is adult. Age of onset can vary across affected individuals.